Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002311073 | SCV000319825 | pathogenic | Familial thoracic aortic aneurysm and aortic dissection | 2015-06-24 | criteria provided, single submitter | clinical testing | The c.404_423del20 variant, located in coding exon 4 of the PLOD1 gene, results from a deletion of 20 nucleotides between positions 404 and 423, causing a translational frameshift with a predicted alternate stop codon. Since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). |
Gene |
RCV000498828 | SCV000590212 | pathogenic | not provided | 2022-01-25 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Truncating variants in this gene are considered pathogenic by a well-established clinical consortium and/or database; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001387123 | SCV001587663 | pathogenic | Ehlers-Danlos syndrome, kyphoscoliotic type 1 | 2025-01-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asp135Valfs*75) in the PLOD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PLOD1 are known to be pathogenic (PMID: 10874315, 21699693). This variant is present in population databases (rs745409628, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with PLOD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 264119). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV001387123 | SCV005638779 | likely pathogenic | Ehlers-Danlos syndrome, kyphoscoliotic type 1 | 2024-06-11 | criteria provided, single submitter | clinical testing |